Expansion of cancer care and control in countries of low and middle income: A call to action

Paul Farmer, Julio Frenk, Felicia M. Knaul, Lawrence N. Shulman, George Alleyne, Lance Armstrong, Rifat Atun, Douglas Blayney, Lincoln Chen, Richard Feachem, Mary Gospodarowicz, Julie Gralow, Sanjay Gupta, Ana Langer, Julian Lob-Levyt, Claire Neal, Anthony Mbewu, Dina Mired, Peter Piot, K. Srinath ReddyJeffrey D. Sachs, Mahmoud Sarhan, John R. Seffrin

Research output: Contribution to journalArticle

Abstract

Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.

Original languageEnglish (US)
Pages (from-to)1186-1193
Number of pages8
JournalThe Lancet
Volume376
Issue number9747
DOIs
StatePublished - Oct 2 2010
Externally publishedYes

Fingerprint

Neoplasms
Developing Countries
Insurance Coverage
National Health Programs
Advisory Committees
Poverty
Psychological Stress
Developed Countries
Caregivers
Health Services
Survival Rate
Public Health
HIV
Delivery of Health Care
Costs and Cost Analysis
Survival
Health
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Farmer, P., Frenk, J., Knaul, F. M., Shulman, L. N., Alleyne, G., Armstrong, L., ... Seffrin, J. R. (2010). Expansion of cancer care and control in countries of low and middle income: A call to action. The Lancet, 376(9747), 1186-1193. https://doi.org/10.1016/S0140-6736(10)61152-X

Expansion of cancer care and control in countries of low and middle income : A call to action. / Farmer, Paul; Frenk, Julio; Knaul, Felicia M.; Shulman, Lawrence N.; Alleyne, George; Armstrong, Lance; Atun, Rifat; Blayney, Douglas; Chen, Lincoln; Feachem, Richard; Gospodarowicz, Mary; Gralow, Julie; Gupta, Sanjay; Langer, Ana; Lob-Levyt, Julian; Neal, Claire; Mbewu, Anthony; Mired, Dina; Piot, Peter; Reddy, K. Srinath; Sachs, Jeffrey D.; Sarhan, Mahmoud; Seffrin, John R.

In: The Lancet, Vol. 376, No. 9747, 02.10.2010, p. 1186-1193.

Research output: Contribution to journalArticle

Farmer, P, Frenk, J, Knaul, FM, Shulman, LN, Alleyne, G, Armstrong, L, Atun, R, Blayney, D, Chen, L, Feachem, R, Gospodarowicz, M, Gralow, J, Gupta, S, Langer, A, Lob-Levyt, J, Neal, C, Mbewu, A, Mired, D, Piot, P, Reddy, KS, Sachs, JD, Sarhan, M & Seffrin, JR 2010, 'Expansion of cancer care and control in countries of low and middle income: A call to action', The Lancet, vol. 376, no. 9747, pp. 1186-1193. https://doi.org/10.1016/S0140-6736(10)61152-X
Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L et al. Expansion of cancer care and control in countries of low and middle income: A call to action. The Lancet. 2010 Oct 2;376(9747):1186-1193. https://doi.org/10.1016/S0140-6736(10)61152-X
Farmer, Paul ; Frenk, Julio ; Knaul, Felicia M. ; Shulman, Lawrence N. ; Alleyne, George ; Armstrong, Lance ; Atun, Rifat ; Blayney, Douglas ; Chen, Lincoln ; Feachem, Richard ; Gospodarowicz, Mary ; Gralow, Julie ; Gupta, Sanjay ; Langer, Ana ; Lob-Levyt, Julian ; Neal, Claire ; Mbewu, Anthony ; Mired, Dina ; Piot, Peter ; Reddy, K. Srinath ; Sachs, Jeffrey D. ; Sarhan, Mahmoud ; Seffrin, John R. / Expansion of cancer care and control in countries of low and middle income : A call to action. In: The Lancet. 2010 ; Vol. 376, No. 9747. pp. 1186-1193.
@article{8442febe6a2d4ecf845b67b93d5ac6b7,
title = "Expansion of cancer care and control in countries of low and middle income: A call to action",
abstract = "Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.",
author = "Paul Farmer and Julio Frenk and Knaul, {Felicia M.} and Shulman, {Lawrence N.} and George Alleyne and Lance Armstrong and Rifat Atun and Douglas Blayney and Lincoln Chen and Richard Feachem and Mary Gospodarowicz and Julie Gralow and Sanjay Gupta and Ana Langer and Julian Lob-Levyt and Claire Neal and Anthony Mbewu and Dina Mired and Peter Piot and Reddy, {K. Srinath} and Sachs, {Jeffrey D.} and Mahmoud Sarhan and Seffrin, {John R.}",
year = "2010",
month = "10",
day = "2",
doi = "10.1016/S0140-6736(10)61152-X",
language = "English (US)",
volume = "376",
pages = "1186--1193",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "9747",

}

TY - JOUR

T1 - Expansion of cancer care and control in countries of low and middle income

T2 - A call to action

AU - Farmer, Paul

AU - Frenk, Julio

AU - Knaul, Felicia M.

AU - Shulman, Lawrence N.

AU - Alleyne, George

AU - Armstrong, Lance

AU - Atun, Rifat

AU - Blayney, Douglas

AU - Chen, Lincoln

AU - Feachem, Richard

AU - Gospodarowicz, Mary

AU - Gralow, Julie

AU - Gupta, Sanjay

AU - Langer, Ana

AU - Lob-Levyt, Julian

AU - Neal, Claire

AU - Mbewu, Anthony

AU - Mired, Dina

AU - Piot, Peter

AU - Reddy, K. Srinath

AU - Sachs, Jeffrey D.

AU - Sarhan, Mahmoud

AU - Seffrin, John R.

PY - 2010/10/2

Y1 - 2010/10/2

N2 - Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.

AB - Substantial inequalities exist in cancer survival rates across countries. In addition to prevention of new cancers by reduction of risk factors, strategies are needed to close the gap between developed and developing countries in cancer survival and the effects of the disease on human suffering. We challenge the public health community's assumption that cancers will remain untreated in poor countries, and note the analogy to similarly unfounded arguments from more than a decade ago against provision of HIV treatment. In resource-constrained countries without specialised services, experience has shown that much can be done to prevent and treat cancer by deployment of primary and secondary caregivers, use of off-patent drugs, and application of regional and global mechanisms for financing and procurement. Furthermore, several middle-income countries have included cancer treatment in national health insurance coverage with a focus on people living in poverty. These strategies can reduce costs, increase access to health services, and strengthen health systems to meet the challenge of cancer and other diseases. In 2009, we formed the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, which is composed of leaders from the global health and cancer care communities, and is dedicated to proposal, implementation, and evaluation of strategies to advance this agenda.

UR - http://www.scopus.com/inward/record.url?scp=77957664584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957664584&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(10)61152-X

DO - 10.1016/S0140-6736(10)61152-X

M3 - Article

C2 - 20709386

AN - SCOPUS:77957664584

VL - 376

SP - 1186

EP - 1193

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9747

ER -